Related references
Note: Only part of the references are listed.SIV-induced terminally differentiated adaptive NK cells in lymph nodes associated with enhanced MHC-E restricted activity
Nicolas Huot et al.
NATURE COMMUNICATIONS (2021)
Synthesis of precision antibody conjugates using proximity-induced chemistry
Yu J. Cao et al.
THERANOSTICS (2021)
Sialic acid-binding immunoglobulin-like lectins (Siglecs) detect self-associated molecular patterns to regulate immune responses
Heinz Laeubli et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2020)
In vivo delivery of synthetic DNA encoded antibodies induces broad HIV-1-neutralizing activity
Megan C. Wise et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Systemic HIV and SIV latency reversal via non-canonical NF-κB signalling in vivo
Christopher C. Nixon et al.
NATURE (2020)
Synthetic nucleic acid antibody prophylaxis confers rapid and durable protective immunity against Zika virus challenge
Hyeree Choi et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2020)
Targeted glycan degradation potentiates the anticancer immune response in vivo
Melissa A. Gray et al.
NATURE CHEMICAL BIOLOGY (2020)
Phenotypic Characterization of SLex+ and CLA+ CD4+ T Cells
Leticia Kuri-Cervantes et al.
STAR PROTOCOLS (2020)
Identification of NK Cell Subpopulations That Differentiate HIV-Infected Subject Cohorts with Diverse Levels of Virus Control
Christopher W. Pohlmeyer et al.
JOURNAL OF VIROLOGY (2019)
Siglec-9 Regulates an Effector Memory CD8+ T-cell Subset That Congregates in the Melanoma Tumor Microenvironment
Quentin Haas et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Sugar Free: Novel Immunotherapeutic Approaches Targeting Siglecs and Sialic Acids to Enhance Natural Killer Cell Cytotoxicity Against Cancer
John Daly et al.
FRONTIERS IN IMMUNOLOGY (2019)
Decreased siglec-9 expression on natural Killer cell subset associated With Persistent hBV replication
Di Zhao et al.
FRONTIERS IN IMMUNOLOGY (2018)
Self-associated molecular patterns mediate cancer immune evasion by engaging Siglecs on T cells
Michal A. Stanczak et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Proximity-Induced Site-Specific Antibody Conjugation
Chenfei Yu et al.
BIOCONJUGATE CHEMISTRY (2018)
HCV viraemia associates with NK cell activation and dysfunction in antiretroviral therapy-treated HIV/HCV-co-infected subjects
E. Papasavvas et al.
JOURNAL OF VIRAL HEPATITIS (2017)
Defining total-body AIDS-virus burden with implications for curative strategies
Jacob D. Estes et al.
NATURE MEDICINE (2017)
Natural killer cells migrate into and control simian immunodeficiency virus replication in lymph node follicles in African green monkeys
Nicolas Huot et al.
NATURE MEDICINE (2017)
A Flow Cytometry-Based Cytotoxicity Assay for the Assessment of Human NK Cell Activity
Fadi Kandarian et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2017)
Siglec-7 restores β-cell function and survival and reduces inflammation in pancreatic islets from patients with diabetes
Gitanjali Dharmadhikari et al.
SCIENTIFIC REPORTS (2017)
Reduced Expression of Siglec-7, NKG2A, and CD57 on Terminally Differentiated CD56-CD16+ Natural Killer Cell Subset Is Associated with Natural Killer Cell Dysfunction in Chronic HIV-1 Clade C Infection
Michael Z. Zulu et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2017)
IFN-α augments natural killer-mediated antibody-dependent cellular cytotoxicity of HIV-1-infected autologous CD4+ T cells regardless of major histocompatibility complex class 1 downregulation
Costin Tomescu et al.
AIDS (2017)
Defective proviruses rapidly accumulate during acute HIV-1 infection
Katherine M. Bruner et al.
NATURE MEDICINE (2016)
Precision glycocalyx editing as a strategy for cancer immunotherapy
Han Xiao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
HIV-1 therapy with monoclonal antibody 3BNC117 elicits host immune responses against HIV-1
Till Schoofs et al.
SCIENCE (2016)
NK Cells in HIV Disease
Eileen Scully et al.
CURRENT HIV/AIDS REPORTS (2016)
Combination of NK Cells and Cetuximab to Enhance Anti-Tumor Responses in RAS Mutant Metastatic Colorectal Cancer
John Pradeep Veluchamy et al.
PLOS ONE (2016)
The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo
Ole S. Sogaard et al.
PLOS PATHOGENS (2015)
Siglec receptors impact mammalian lifespan by modulating oxidative stress
Flavio Schwarz et al.
ELIFE (2015)
Short-term administration of disulfiram for reversal of latent HIV infection: a phase 2 dose-escalation study
Julian H. Elliott et al.
LANCET HIV (2015)
A Pilot Study Assessing the Safety and Latency-Reversing Activity of Disulfiram in HIV-1-Infected Adults on Antiretroviral Therapy
Adam M. Spivak et al.
CLINICAL INFECTIOUS DISEASES (2014)
Interactions between Siglec-7/9 receptors and ligands influence NK cell-dependent tumor immunosurveillance
Camilla Jandus et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
HIV-1 Expression Within Resting CD4+ T Cells After Multiple Doses of Vorinostat
Nancy M. Archin et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Activation of NK cells is associated with HIV-1 disease progression
Leticia Kuri-Cervantes et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2014)
Glycocalyx engineering reveals a Siglec-based mechanism for NK cell immunoevasion
Jason E. Hudak et al.
NATURE CHEMICAL BIOLOGY (2014)
Activation of HIV Transcription with Short-Course Vorinostat in HIV-Infected Patients on Suppressive Antiretroviral Therapy
Julian H. Elliott et al.
PLOS PATHOGENS (2014)
Replication-Competent Noninduced Proviruses in the Latent Reservoir Increase Barrier to HIV-1 Cure
Ya-Chi Ho et al.
CELL (2013)
The Distribution of HIV DNA and RNA in Cell Subsets Differs in Gut and Blood of HIV-Positive Patients on ART: Implications for Viral Persistence
Steven A. Yukl et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Natural killer cells in HIV controller patients express an activated effector phenotype and do not up-regulate NKp44 on IL-2 stimulation
Francesco Marras et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Sialic acid-binding Ig-like lectin-7 interacts with HIV-1 gp120 and facilitates infection of CD4pos T cells and macrophages
Stefania Varchetta et al.
RETROVIROLOGY (2013)
Post-Treatment HIV-1 Controllers with a Long-Term Virological Remission after the Interruption of Early Initiated Antiretroviral Therapy ANRS VISCONTI Study
Asier Saez-Cirion et al.
PLOS PATHOGENS (2013)
Multifarious roles of sialic acids in immunity
Ajit Varki et al.
GLYCOBIOLOGY OF THE IMMUNE RESPONSE (2012)
Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy
N. M. Archin et al.
NATURE (2012)
Innate or Adaptive Immunity? The Example of Natural Killer Cells
Eric Vivier et al.
SCIENCE (2011)
Identification of Siglec-9 as the receptor for MUC16 on human NK cells, B cells, and monocytes
Jennifer A. Belisle et al.
MOLECULAR CANCER (2010)
Functionally distinct subsets of human NK cells and monocyte/DC-like cells identified by coexpression of CD56, CD7, and CD4
Jeffrey M. Milush et al.
BLOOD (2009)
The decreased expression of Siglec-7 represents an early marker of dysfunctional natural killer-cell subsets associated with high levels of HIV-1 viremia
Enrico Brunetta et al.
BLOOD (2009)
NK cell lysis of HIV-1-infected autologous CD4 primary T cells: Requirement for IFN-mediated NK activation by plasmacytoid dendritic cells
Costin Tomescu et al.
JOURNAL OF IMMUNOLOGY (2007)
Human immunodeficiency virus type 1 RNA levels in different regions of human brain: Quantification using real-time reverse transcriptase-polymerase chain reaction
Adarsh M. Kumar et al.
JOURNAL OF NEUROVIROLOGY (2007)
Siglecs and their roles in the immune system
Paul R. Crocker et al.
NATURE REVIEWS IMMUNOLOGY (2007)
A simplified method for the rapid fluorometric assessment of antibody-dependent cell-mediated cytotoxicity
VR Gómez-Román et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2006)
Characterization of CD56-/CD16+ natural killer (NK) cells:: A highly dysfunctional NK subset expanded in HIV-infected viremic individuals
D Mavilio et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
The membrane-proximal immunoreceptor tyrosine-based inhibitory motif is critical for the inhibitory signaling mediated by siglecs-7 and-9, CD33-related Siglecs expressed on human monocytes and NK cells
T Avril et al.
JOURNAL OF IMMUNOLOGY (2004)
Negative regulation of T cell receptor signaling by Siglec-7 (p70/AIRM) and Siglec-9
Y Ikehara et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Natural killer cells, viruses and cancer
A Cerwenka et al.
NATURE REVIEWS IMMUNOLOGY (2001)
Siglec-9, a novel sialic acid binding member of the immunoglobulin superfamily expressed broadly on human blood leukocytes
JQ Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
